验证数据展示
经过测试的应用
Positive WB detected in | human plasma |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:1000-1:8000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
25891-1-AP targets C9 in WB, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, ELISA Application Description |
经测试反应性 | human |
免疫原 | C9 fusion protein Ag23137 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | complement component 9 |
别名 | C9, complement component 9, Complement component C9 |
计算分子量 | 559 aa, 63 kDa |
观测分子量 | 64 kDa |
GenBank蛋白编号 | BC020721 |
基因名称 | C9 |
Gene ID (NCBI) | 735 |
RRID | AB_3085827 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P02748 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
The final consequence of complement activation is the formation of the membrane attack complex (MAC), a multiprotein assembly that perforates cell membranes, forming transmembrane channels. The MAC plays a critical role in complement-mediated hemolysis and inflammasome activation (PMID: 27444648). Complement component 9 (C9) is 1 of 5 late-acting proteins of complement that participate in the assembly and function of the MAC. C9 may be cleaved by thrombin to generate fragments C9a (25 kDa) and C9b (37 kDa) (PMID: 7523406).
实验方案
Product Specific Protocols | |
---|---|
WB protocol for C9 antibody 25891-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |